It doesn’t take much to get Vinay Prasad, MD, started. Throw out a few ideas….
Cancer Moonshot.
Precision Medicine.
Over promotion of surrogate endpoints.
Over promotion of screening tests.
News coverage of medical journals.
Words like revolutionary…game-changer…miracle…breakthrough…home run.
….and you’re off to the races.
He’s only 33 but he has already earned respect as a hematologist-oncologist now at the Oregon Health and Sciences University with appointments in the Division of Public Health and Preventive Medicine, and as a Senior Scholar in the Center for Health Care Ethics.
He and I have connected via social media for some time. (He Tweets as @VinayPrasad82.) We finally sat down for this podcast interview:
Links to items mentioned in the podcast:
Portland Tribune story, “Remedy for a sick industry.”
Why a Cancer Moonshot is Unlikely to Give us a Cure. Washington Post
On Precision and Genomic Medicine: Genetics-based medicine a matter of debate Bend Bulletin.
The FDA’s Use of Untested Surrogate Endpoints
Study raises questions FDA standards on new cancer drugs. Milwaukee Journal Sentinel.
We are spending 107 billion in cancer drugs, is it worth it? Washington Post
Why cancer screening has never been shown to “save lives” – It is Misleading to Say Cancer Screening Saves Lives. Newsweek.
Media Coverage of Medical Journals: Does the Media Select the best stories? Medical News: Evidence Not a Factor – Medpage Today.
Many other articles about his work.
Thanks to The National Institute for Health Care Management Foundation for providing us with a grant to produce these podcasts.
Credit: podcast editor Mitch Skinner
Please note: if you have listened to any of our podcasts and like what you’ve heard, we’d appreciate it if you’d leave a Review and a Rating on the iTunes webpage where our podcasts can be found: https://itun.es/i6S86Qw. (You need to click on the “View in iTunes” button on the left of that page, then find the Ratings and Reviews tab.)
You can now subscribe to our podcasts on that iTunes page or via this RSS feed: http://feeds.soundcloud.com/users/soundcloud:users:167780656/sounds.rss
All episodes of our podcasts are archived on this page on HealthNewsReview.org.
Comments
Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.
Our Comments Policy
But before leaving a comment, please review these notes about our policy.
You are responsible for any comments you leave on this site.
This site is primarily a forum for discussion about the quality (or lack thereof) in journalism or other media messages (advertising, marketing, public relations, medical journals, etc.) It is not intended to be a forum for definitive discussions about medicine or science.
We will delete comments that include personal attacks, unfounded allegations, unverified claims, product pitches, profanity or any from anyone who does not list a full name and a functioning email address. We will also end any thread of repetitive comments. We don”t give medical advice so we won”t respond to questions asking for it.
We don”t have sufficient staffing to contact each commenter who left such a message. If you have a question about why your comment was edited or removed, you can email us at feedback@healthnewsreview.org.
There has been a recent burst of attention to troubles with many comments left on science and science news/communication websites. Read “Online science comments: trolls, trash and treasure.”
The authors of the Retraction Watch comments policy urge commenters:
We”re also concerned about anonymous comments. We ask that all commenters leave their full name and provide an actual email address in case we feel we need to contact them. We may delete any comment left by someone who does not leave their name and a legitimate email address.
And, as noted, product pitches of any sort – pushing treatments, tests, products, procedures, physicians, medical centers, books, websites – are likely to be deleted. We don”t accept advertising on this site and are not going to give it away free.
The ability to leave comments expires after a certain period of time. So you may find that you’re unable to leave a comment on an article that is more than a few months old.